What is the mechanism of action of Ibritumomab?
•
4 min read
Ibritumomab is part of a therapeutic regimen known as Zevalin, which combines a targeted monoclonal antibody with a radioactive isotope to treat specific types of B-cell non-Hodgkin's lymphoma. To fully grasp its efficacy, it is crucial to understand **what is the mechanism of action of Ibritumomab?**
